The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
A Manganese Alternative to Gadolinium for MRI Contrast
Open accessAbstract
Contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) are routinely used to diagnose soft tissue and vascular abnormalities. However, safety concerns limit the use of iodinated and gadolinium (Gd)-based CT and MRI contrast media in renally compromised patients. With an estimated 14% of the US population suffering from chronic kidney disease (CKD), contrast media compatible with renal impairment is sorely needed. We present the new manganese(II) complex [Mn(PyC3A)(H2O)](-) as a Gd alternative. [Mn(PyC3A)(H2O)](-) is among the most stable Mn(II) complexes at pH 7.4 (log KML = 11.40). In the presence of 25 mol equiv of Zn at pH 6.0, 37 °C, [Mn(PyC3A)(H2O)](-) is 20-fold more resistant to dissociation than [Gd(DTPA)(H2O)](2-). Relaxivity of [Mn(PyC3A)(H2O)](-) in blood plasma is comparable to commercial Gd contrast agents. Biodistribution analysis confirms that [Mn(PyC3A)(H2O)](-) clears via a mixed renal/hepatobiliary pathway with >99% elimination by 24 h. [Mn(PyC3A)(H2O)](-) was modified to form a bifunctional chelator and 4 chelates were conjugated to a fibrin-specific peptide to give Mn-FBP. Mn-FBP binds the soluble fibrin fragment DD(E) with Kd = 110 nM. Per Mn relaxivity of Mn-FBP is 4-fold greater than [Mn(PyC3A)(H2O)](-) and increases 60% in the presence of fibrin, consistent with binding. Mn-FBP provided equivalent thrombus enhancement to the state of the art Gd analogue, EP-2104R, in a rat model of arterial thrombosis. Mn metabolite analysis reveals no evidence of dechelation and the probe was >99% eliminated after 24 h. [Mn(PyC3A)(H2O)](-) is a lead development candidate for an imaging probe that is compatible with renally compromised patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications
Caravan, P., Ellison, J. J., McMurry, T. J., & Lauffer, R. B. (1999) · Chemical Reviews · doi:10.1021/cr980440x · Cited by 4,483
Self-citationParamagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design
Lauffer, R. B. (1987) · Chemical Reviews · doi:10.1021/cr00081a003 · Cited by 1,978
Hospital-acquired renal insufficiency
Nash, K., Hafeez, A., & Hou, S. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32766 · Cited by 1,951
Grobner, T. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfk062 · Cited by 1,859
Rohrer, M., Bauer, H., Mintorovitch, J., Requardt, M., & Weinmann, H.-J. (2005) · Investigative Radiology · doi:10.1097/01.rli.0000184756.66360.d3 · Cited by 1,682
Marckmann, P., Skov, L., Rossen, K., Dupont, A., Damholt, M. B., Heaf, J. G., & Thomsen, H. S. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006060601 · Cited by 1,400
Intracranial gadolinium deposition after contrast-enhanced MR imaging
McDonald, R. J., McDonald, J. S., Kallmes, D. F., Jentoft, M. E., Murray, D. L., Thielen, K. R., Williamson, E. E., & Eckel, L. J. (2015) · Radiology · doi:10.1148/radiol.15150025 · Cited by 1,358
Kanda, T., Ishii, K., Kawaguchi, H., Kitajima, K., & Takenaka, D. (2014) · Radiology · doi:10.1148/radiol.13131669 · Cited by 1,339
Kanda, T., Fukusato, T., Matsuda, M., Toyoda, K., Oba, H., Kotoku, J., Haruyama, T., Kitajima, K., & Furui, S. (2015) · Radiology · doi:10.1148/radiol.2015142690 · Cited by 874
Caravan, P., Farrar, C. T., Frullano, L., & Uppal, R. (2009) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.267 · Cited by 513
Self-citationKanda, T., Osawa, M., Oba, H., Toyoda, K., Kotoku, J., Haruyama, T., Takeshita, K., & Furui, S. (2015) · Radiology · doi:10.1148/radiol.14140364 · Cited by 472
Emerging applications for ferumoxytol as a contrast agent in MRI
Bashir, M. R., Bhatti, L., Marin, D., & Nelson, R. C. (2015) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24691 · Cited by 371
Aime, S., Castelli, D. D., Crich, S. G., Gianolio, E., & Terreno, E. (2009) · Accounts of Chemical Research · doi:10.1021/ar800192p · Cited by 350
Solomon, R. J., Natarajan, M. K., Doucet, S., Sharma, S. K., Staniloae, C. S., Katholi, R. E., Gelormini, J. L., Labinaz, M., Moreyra, A. E., & the Investigators of the CARE Study (2007) · Circulation · doi:10.1161/circulationaha.106.671644 · Cited by 346
The Scope of Coronary Heart Disease in Patients With Chronic Kidney Disease
Hage, F. G., Venkataraman, R., Zoghbi, G. J., Perry, G. J., DeMattos, A. M., & Iskandrian, A. E. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.047 · Cited by 247
EP-2104R: A Fibrin-Specific Gadolinium-Based MRI Contrast Agent for Detection of Thrombus
Overoye-Chan, K., Koerner, S., Looby, R. J., Kolodziej, A. F., Zech, S. G., Deng, Q., Chasse, J. M., McMurry, T. J., & Caravan, P. (2008) · Journal of the American Chemical Society · doi:10.1021/ja800834y · Cited by 226
Self-citationMR imaging of thrombi using EP-2104R, a fibrin-specific contrast agent: initial results in patients
Spuentrup, E., Botnar, R. M., Wiethoff, A. J., Ibrahim, T., Kelle, S., Katoh, M., Özgun, M., Nagel, E., Vymazal, J., Graham, P. B., et al. (2008) · European Radiology · doi:10.1007/s00330-008-0965-2 · Cited by 188
Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients.
Hamm, B., Vogl, T. J., Branding, G., Schnell, B., Taupitz, M., Wolf, K. J., & Lissner, J. (1992) · Radiology · doi:10.1148/radiology.182.1.1309218 · Cited by 175
Vymazal, J., Spuentrup, E., Cardenas-Molina, G., Wiethoff, A. J., Hartmann, M. G., Caravan, P., & Parsons, E. C. (2009) · Investigative Radiology · doi:10.1097/rli.0b013e3181b092a7 · Cited by 167
Self-citationSynthesis and Evaluation of a High Relaxivity Manganese(II)-Based MRI Contrast Agent
Troughton, J. S., Greenfield, M. T., Greenwood, J. M., Dumas, S., Wiethoff, A. J., Wang, J., Spiller, M., McMurry, T. J., & Caravan, P. D. (2004) · Inorganic Chemistry · doi:10.1021/ic049559g · Cited by 158
Self-citationCaravan, P. D., Parigi, G., Chasse, J. M., Cloutier, N. J., Ellison, J. J., Lauffer, R. B., Luchinat, C., McDermid, S. A., Spiller, M., & McMurry, T. J. (2007) · Inorganic Chemistry · doi:10.1021/ic700686k · Cited by 154
Self-citationCurrent status of nephrogenic systemic fibrosis
Besheli, L. D., Aran, S., Shaqdan, K., Kay, J., & Abujudeh, H. H. (2014) · Clinical Radiology · doi:10.1016/j.crad.2014.01.003 · Cited by 119
Gale, E. M., Zhu, J., & Caravan, P. D. (2013) · Journal of the American Chemical Society · doi:10.1021/ja4094132 · Cited by 113
Self-citationUppal, R., Catana, C., Ay, İ., et al. (2010) · Radiology · doi:10.1148/radiol.10100881 · Cited by 96
Self-citationGale, E. M., Mukherjee, S., Liu, C., Loving, G. S., & Caravan, P. D. (2014) · Inorganic Chemistry · doi:10.1021/ic502005u · Cited by 90
Self-citationDynamic Contrast-Enhanced Breast MR Imaging
Moon, M., Cornfeld, D., & Weinreb, J. C. (2009) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2009.01.010 · Cited by 74
Cerebral Perfusion Imaging using Contrast-enhanced MRI
Keston, P. M., Murray, A. D., & Jackson, A. (2003) · Clinical Radiology · doi:10.1016/s0009-9260(03)00130-2 · Cited by 64
Impact of Comorbidities on Mortality in Managed Care Patients With CKD
Gullion, C. M., Keith, D. S., Nichols, G. A., & Smith, D. H. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.04.083 · Cited by 62
Fibrin-Targeted PET Probes for the Detection of Thrombi
Ciesienski, K. L., Yang, Y., Ay, İ., Chonde, D. B., Loving, G. S., Rietz, T. A., Catana, C., & Caravan, P. D. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300610s · Cited by 60
Self-citationAy, İ., Blasi, F., Rietz, T. A., Rotile, N. J., Kura, S., Brownell, A.-L., Day, H., Oliveira, B. L., Looby, R. J., & Caravan, P. D. (2014) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.113.001806 · Cited by 50
Self-citationMn‐DPDP enhancement patterns of hepatocellular lesions on MR images
Vogl, T. J., Hamm, B., Schnell, B., et al. (1993) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880030110 · Cited by 48
Effect of Pyridyl Donors in the Chelation of Aluminum(III), Gallium(III), and Indium(III)
Caravan, P. D., Rettig, S. J., & Orvig, C. (1997) · Inorganic Chemistry · doi:10.1021/ic961230a · Cited by 35
Self-citationMolecular Imaging of Fibrin in a Breast Cancer Xenograft Mouse Model
Uppal, R., Medarova, Z. O., Farrar, C. T., Dai, G., Moore, A. V., & Caravan, P. D. (2012) · Investigative Radiology · doi:10.1097/rli.0b013e31825dddfb · Cited by 34
Self-citationUse of Contrast Media in Neuroimaging
Essig, M., Dinkel, J., & Gutierrez, J. E. (2012) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2012.08.001 · Cited by 34
Cited by
Nanotechnology for Multimodal Synergistic Cancer Therapy
Fan, W., Yung, B., Huang, P., & Chen, X. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00258 · Cited by 1,791
Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers
Wahsner, J., Gale, E. M., Rodríguez-Rodríguez, A., & Caravan, P. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00363 · Cited by 1,603
Self-citationJia, Q., Ge, J., Liu, W., Zheng, X., Chen, S., Wen, Y., Zhang, H., & Wang, P. (2018) · Advanced Materials · doi:10.1002/adma.201706090 · Cited by 509
Radioactive Transition Metals for Imaging and Therapy
Boros, E., & Packard, A. B. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00281 · Cited by 299
Li, B., Gu, Z., Kurniawan, N., Chen, W., & Xu, Z. P. (2017) · Advanced Materials · doi:10.1002/adma.201700373 · Cited by 258
Metadata
- Authors
- Gale, E. M., Atanasova, I. P., Blasi, F., Ay, I., & Caravan, P.
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-12-04
- Volume
- 137
- Issue
- 49
- Pages
- 15548-15557
- ISSN
- 0002-7863 (ISSN-L)
- 1520-5126
- OpenAlex
- W2247895134
- Cited by
- 353
- References
- 35
- FWCI
- 9.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.